Recent content by generactor

In a call last August or September Nader admitted that the price structure of the Vyera licensing deal for HIV in the US essentially killed any chance for a partnership on other indications. There is a price floor in the Vyera contract which extends to any indication, I believe it's somewhere...

A way to gauge it premarket is to watch what happens to the stock on the Stuttgart exchange, which will open at 2 AM EST Monday. https://www.bloomberg.com/quote/296:GR

The last patient would have hit 60 days around Feb 14th.

Those patients in the RLFTF chart are from their extended label trial last summer, not their clinical trial and are in the worst of the worst condition. They are the ones that were excluded from the RLFTF trial because of the severity of their illness. That's why the death rate is so high. Do...